Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that primary safety endpoints of a Phase 2a, randomized, double-blind, placebo-controlled trial of setanaxib in patients ...
43mon MSN
Bharat Electronics shares extend rally for third straight session on ₹792 crore order win, rise 2%
Bharat Electronics Ltd (BEL) continued its upward trend, gaining 2% to ₹425.50 after announcing new orders worth ₹792 crore.
Defence PSU BEL rose 2% to Rs 425.50 on Tuesday, marking its third straight gain after announcing another major order win.
Facebook is retiring its famous Like and Comment buttons from external websites starting February 10, 2026. Here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback